These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 7879050)
1. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells. Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050 [No Abstract] [Full Text] [Related]
2. Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A. Sigal NH; Lin CS; Siekierka JJ Transplant Proc; 1991 Apr; 23(2 Suppl 2):1-5. PubMed ID: 1712132 [No Abstract] [Full Text] [Related]
3. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression. Chae DW; Nosaka Y; Strom TB; Maslinski W J Immunol; 1996 Oct; 157(7):2813-9. PubMed ID: 8816384 [TBL] [Abstract][Full Text] [Related]
4. Rapamycin inhibits the in vitro release of soluble interleukin-2 receptor by activated peripheral blood mononuclear cells (PBMC) independently of the mode of activation. Degiannis D; Hornung N Int J Immunopharmacol; 1995 Jul; 17(7):593-6. PubMed ID: 8586487 [TBL] [Abstract][Full Text] [Related]
5. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model. Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457 [No Abstract] [Full Text] [Related]
6. Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner. Su MS; Semerjian A Transplant Proc; 1991 Dec; 23(6):2912-5. PubMed ID: 1721310 [No Abstract] [Full Text] [Related]
7. Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation. Ryffel B; Willcocks JL; Brooks N; Woerly G Immunopharmacology; 1995 Sep; 30(3):199-207. PubMed ID: 8557519 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporine and rapamycin block protein kinase C-mediated induction of the activation signal, activator of DNA replication, in cell-free assay. Kimball P; Kerman RH; Williams J; Kahan BD Transplant Proc; 1993 Feb; 25(1 Pt 1):518-9. PubMed ID: 8438397 [No Abstract] [Full Text] [Related]
9. The influence of cyclosporin A on lymphocyte attenuator expression. Zeng C; Zhen Y; Shu SA; Wu T; Yi H; Lian ZX; Zhao Y J Autoimmun; 2007 Jun; 28(4):234-44. PubMed ID: 17449225 [TBL] [Abstract][Full Text] [Related]
10. Rapamycin suppresses in vitro immunoglobulin production by human lymphocytes. Luo H; Chen H; Daloze P; Chang J; Wu J Transplant Proc; 1991 Aug; 23(4):2236-8. PubMed ID: 1871858 [No Abstract] [Full Text] [Related]
11. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin. Dumont FJ; Kastner CA J Cell Physiol; 1994 Jul; 160(1):141-53. PubMed ID: 8021294 [TBL] [Abstract][Full Text] [Related]
12. Opposing effects of rapamycin and cyclosporin A on activation-induced Ca(2+) release. Almawi WY; Assi JW; Chudzik DM; Lazarovits AI Eur J Pharmacol; 1999 Sep; 381(1):51-6. PubMed ID: 10528133 [TBL] [Abstract][Full Text] [Related]
13. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin. Teutsch M; Higer M; Wang D; Wortis HW Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861 [TBL] [Abstract][Full Text] [Related]
14. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation. Hess DA; Bird IA; Almawi WY; Rieder MJ J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542 [TBL] [Abstract][Full Text] [Related]
15. Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression. Chong AS; Gebel H; Finnegan A; Petraitis EE; Jiang XL; Sankary HN; Foster P; Williams JW Transplant Proc; 1993 Feb; 25(1 Pt 1):747-9. PubMed ID: 8438466 [No Abstract] [Full Text] [Related]
16. Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells. Pockley AG; Williams S; Reid SD; Bowles MJ Biochem Soc Trans; 1995 Nov; 23(4):615S. PubMed ID: 8654800 [No Abstract] [Full Text] [Related]
17. Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin. Luo H; Chen H; Daloze P; St-Louis G; Wu J Clin Exp Immunol; 1993 Nov; 94(2):371-6. PubMed ID: 8222329 [TBL] [Abstract][Full Text] [Related]
18. In vitro expression of activation markers and lymphocyte proliferation in response to interleukin 12: effect of immunosuppressive agents. Degiannis D; Koniavitou K Transplant Proc; 1996 Dec; 28(6):3062-4. PubMed ID: 8962187 [No Abstract] [Full Text] [Related]
19. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes. Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382 [No Abstract] [Full Text] [Related]
20. Evidence that rapamycin inhibits interleukin-12-induced proliferation of activated T lymphocytes. Bertagnolli MM; Yang L; Herrmann SH; Kirkman RL Transplantation; 1994 Nov; 58(10):1091-6. PubMed ID: 7974715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]